Eleven months after launching with $60 million in hand, Ventus Therapeutics raised another $100 million to drive the company’s pipeline toward the clinic.
The head of the U.S. Centers for Disease Control and Prevention said on Feb. 26 that a recent decline in COVID-19 cases may be stalling, a development she described as concerning while urging that safeguards to fight the virus remain in place.
Bristol Myers Squibb announced plans for a new manufacturing plant in Devens, Mass., adding to the company’s cell therapy network.
A winter storm that blasted the U.S. Northeast with snow, rain and gusty winds was likely to dump a foot (30 cm) or more of snow on parts of New England before heading out to sea.
Initially traced to about 100 cases of Covid-19 that spread across the United States, the number of infections linked to a Biogen corporate conference held in February 2020 at the Boston Marriott Long Wharf Hotel has grown exponentially and researchers estimate the total could be as many as 300,000.
The U.S. death toll from Covid-19 surpassed a grim new milestone of 250,000 lives lost as New York City’s public school system – the nation’s largest – called a halt to in-classroom instruction, citing a jump in coronavirus infection rates.
New York, the former epicenter of the U.S. Covid-19 pandemic, became the fourth U.S. state to surpass half a million coronavirus cases amid a nationwide surge in infections.
Students in Boston’s public schools will shift to remote learning due to the rising Covid-19 infection rate in the city that was ravaged by the pandemic in the spring.
The number of tests coming back positive for Covid-19 is topping 25% in several states in the U.S. Midwest as cases and hospitalizations also surge in the region, according to a Reuters analysis.
Takeda Pharmaceutical opened a new 24,000-square-foot R&D cell therapy manufacturing facility in Boston at the site of the company’s R&D headquarters.